Risk of endometrial cancer in asymptomatic postmenopausal patients with thickened endometrium: data from the FAME-Endo study: an observational register study
To evaluate the risk for endometrial cancer (EC) in a large series of asymptomatic patients with thickened endometrium at ultrasound examination based on previously published data of a theoretical cohort.
In a prospective register study, a total of 1024 women with thickened endometrium in ultrasound examination undergoing histological diagnosis by dilation, hysteroscopy and curettage were evaluated. 124 patients were excluded due to current medication with tamoxifen and/or presence of HNPCC leaving 900 patients for further analysis.
Mean [standard deviation (SD)] age of patients was 65.6 (8.6) years. Mean (SD) endometrial thickness was 11.9 (5.8) mm. 32 and 6 cases of EC and complex endometrial hyperplasia with atypia were found, respectively. In the univariate analysis, a statistically significant association between endometrial thickness, current use of antihypertensive medication, number of deliveries, and the presence of endometrial fluid in preoperative vaginal ultrasound (p < 0.05) with EC was found. A multivariate logistic regression model incorporating these parameters showed a statistically significant independent association of endometrial thickness, number of deliveries, and the presence of endometrial fluid in preoperative vaginal ultrasound (p < 0.05), but not current use of antihypertensive medication, with EC. Using a cut-off of the endometrial thickness of > 11 mm, the risk for “EC alone” and “EC and complex endometrial hyperplasia with atypia combined” was found to be 6.7% and 7.9%, respectively.
Our data compare favorably to a theoretical cohort suggesting a clinically reasonable cut-off of > 11 mm endometrial thickness to discriminate between “normal” and “pathological”. The data regarding “risk for endometrial cancer” can be used for counseling affected women.
KeywordsThickened endometrium Endometrial cancer Cut-off Screening Endometrial thickness Endometrial diameter
LH: Protocol/project development, Data analysis, Manuscript writing/editing. JL: Data collection or management, Protocol/project development, Data analysis, Manuscript writing/editing. SK: Data collection or management. HL: Data collection or management. CS: Data collection or management. BT: Data collection or management. CS: Data collection or management, Manuscript editing. AC-K: Data collection or management. AR: Protocol/project development Data collection or management, Manuscript editing.
Compliance with ethical standards
Approval for this study was obtained by the respective Institutional Review Boards (EK 484/2009).
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study formal consent is not required.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Institute. NC Surveillance, Epidemiology, and End Result Program. http://seer.cancer.gov/statfacts/html/corp.html. Accessed 12 Dec 2017
- 4.Yasa C, Dural O, Bastu E, Ugurlucan FG, Nehir A, Iyibozkurt AC (2016) Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women. Arch Gynecol Obstet 294(2):311–316. https://doi.org/10.1007/s00404-016-4054-5 CrossRefPubMedGoogle Scholar
- 9.Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW (2010) Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 116(1):160–167. https://doi.org/10.1097/AOG.0b013e3181e3e7e8 CrossRefPubMedGoogle Scholar
- 12.Gull B, Karlsson B, Milsom I, Granberg S (2003) Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 188(2):401–408CrossRefPubMedGoogle Scholar
- 13.Wong AS, Lao TT, Cheung CW, Yeung SW, Fan HL, Ng PS, Yuen PM, Sahota DS (2016) Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study. BJOG Int J Obstet Gynaecol 123(3):439–446. https://doi.org/10.1111/1471-0528.13342 CrossRefGoogle Scholar
- 14.Fleischer AC, Wheeler JE, Lindsay I, Hendrix SL, Grabill S, Kravitz B, MacDonald B (2001) An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 184(2):70–75. https://doi.org/10.1067/mob.2001.111088 CrossRefPubMedGoogle Scholar
- 18.Breijer MC, Peeters JA, Opmeer BC, Clark TJ, Verheijen RH, Mol BW, Timmermans A (2012) Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 40(6):621–629. https://doi.org/10.1002/uog.12306 CrossRefPubMedGoogle Scholar
- 19.Laiyemo R, Dudill W, Jones SE, Browne H (2016) Do postmenopausal women with thickened endometrium on trans-vaginal ultrasound in the absence of vaginal bleeding need hysteroscopic assessment? A Pilot Study. J Obstet Gynaecol 36(2):223–226. https://doi.org/10.3109/01443615.2015.1050649 CrossRefPubMedGoogle Scholar
- 24.Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW, Amso NN, Turner G, Brunell C, Fletcher G, Rangar R, Ford K, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Scott I, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Skates SJ, Fallowfield L, Parmar M, Campbell S, Menon U (2011) Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol 12(1):38–48. https://doi.org/10.1016/S1470-2045(10)70268-0 CrossRefPubMedGoogle Scholar
- 25.Gentry-Maharaj A, Sharma A, Burnell M, Ryan A, Amso NN, Seif MW, Turner G, Brunell C, Fletcher G, Rangar R, Fallowfield L, Campbell S, Jacobs I, Menon U (2013) Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound Obstet Gynecol 41(1):73–79. https://doi.org/10.1002/uog.12262 CrossRefPubMedGoogle Scholar